Kırmızı Göz
Özet
Kırmızı göz, konjonktiva damarlarının genişlemesiyle ortaya çıkan ve konjonktivit, blefarit, korneal abrazyon gibi pek çok farklı etkene bağlı gelişebilen yaygın bir klinik belirtidir. Bu durum genellikle birinci basamak sağlık hizmetlerinde tedavi edilebilirken; şiddetli ağrı, görme kaybı veya kornea tutulumu gibi durumlarda mutlaka uzman bir göz hekimine danışılması hayati önem taşır. Makalede, özellikle bulaşıcı olan viral ve bakteriyel konjonktivitlerin ayrımı, alerjik durumlar ve acil müdahale gerektiren glokom atağı gibi sistemik bağlantılı hastalıkların tanı ve tedavi süreçleri detaylandırılmaktadır.
Red eye is a common clinical sign resulting from the dilation of conjunctival vessels, caused by various factors such as conjunctivitis, blepharitis, and corneal abrasion. While it can generally be managed in primary care settings, consulting an ophthalmologist is crucial when accompanied by severe pain, vision loss, or corneal involvement. The text details the differentiation of infectious conjunctivitis, allergic conditions, and the diagnosis and treatment of systemic-related diseases, including emergencies like acute angle-closure glaucoma.
Referanslar
Shields SR. Managing eye disease in primary care. Part 2. How to recognize and treat common eye problems. Postgrad Med. 2000 Oct. 108(5):83-6, 91-6.
Wirbelauer C. Management of the red eye for the primary care physician. Am J Med. 2006 Apr. 119(4):302-6.
Pflipsen M, Massaquoi M, Wolf S: Evaluation of the painful eye. Am Fam Physician 2016; 93: 991–8.
Cronau H, Kankanala RR, Mauger T: Diagnosis and management of red eye in primary care. Am Fam Physician 2010; 81: 137–44.
Teo MA: Improving acute eye consultations in general practice: a practical approach. BMJ Qual Improv Rep. 2014; 3: pii: u206617.w2852
Aslam TM, Tan SZ, Dhillon B. Iris recognition in the presence of ocular disease. J R Soc Interface. 2009 May 6. 6(34):489-93.
Basic and Clinical Science Course, Section 7: Orbit, Eyelids, and Lacrimal System. San Francisco: American Academy of Ophthalmology.
Basic and Clinical Science Course, Section 8: External Disease and Cornea. San Francisco: American Academy of Ophthalmology.
Petersen I, Hayward AC. Antibacterial prescribing in primary care. J Antimicrob Chemother. 2007;60(suppl 1):i43-47
Pavan-Langston D. Manual of Ocular Diagnosis and Therapy. 5th ed. 2007.
American Academy of Ophthalmology. Preferred practice patterns. Conjunctivitis. September 2008. http://one.aao.org/CE/PracticeGuidelines/ PPP.aspx. Accessed September 3, 2009.
Leibowitz HM. The red eye. N Engl J Med. 2000;343(5):345-351.
Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998;57(4): 735-746.
Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am. 2008;28(1):43-58.
Bradford, Cynthia A, ed: Basic Ophthalmology for Medical Students and Primary Care Residents. 8th ed. San Francisco: American Academy of Ophthalmology; 2004
Galor A, Jeng BH. Red eye for the internist: when to treat, when to refer. Cleve Clin J Med. 2008;75(2):137-144
Rietveld RP, ter Riet G, Bindels PJ, et al. Predicting bacterial cause in infectious conjunctivitis. BMJ. 2004;329(7459):206-210
Sheikh A, Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006(2):CD001211
Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008; 86(1):5-17.
Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43(2):170-179.
American Academy of Ophthalmology. Preferred practice pattern. Blepharitis. http://one.aao.org/CE/PracticeGuidelines/PPP.aspx. Accessed September 3, 2009.
Tullo A. Pathogenesis and management of herpes simplex virus keratitis. Eye. 2003;17(8):919-922.
Turner A, Rabiu M. Patching for corneal abrasion. Cochrane Database Syst Rev. 2006(2):CD004764.
Williams CP, Browning AC, Sleep TJ, et al. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. Eye. 2005;19(7):739-7
Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalance of dry eye syndrome among U.S. women. Am J Ophthalmol. 2003;136(2):318-326
Pong JC, Lam DK, Lai JS. Spontaneous subconjunctival haemorrhage secondary to carotid-cavernous fistula. Clin Experiment Ophthalmol. 2008 Jan-Feb. 36(1):90-1.
Quezada AA, Shields CL, Wagner RS et al. Lymphangioma of the conjunctiva and nasal cavity in a child presenting with diffuse subconjunctival hemorrhage and nosebleeds. J Pediatr Ophthalmol Strabismus. 2007 May-Jun. 44(3):180-2.
Mimura T, Usui T, Yamagami S, et al. Recent causes of subconjunctival hemorrhage. Ophthalmologica. 2010. 224(3):133-7
Mimura T, Yamagami S, Mori M, et al. Contact lens-induced subconjunctival hemorrhage. Am J Ophthalmol. 2010 Nov. 150(5):656-665.e1.
Spitzer SG, Luorno J, Noël LP. Isolated subconjunctival hemorrhages in nonaccidental trauma. J AAPOS. 2005 Feb. 9(1):53-6.
Fernandes M, Vira D, Medikonda R, et al. Extensively and pandrug resistant pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome. Graefes Arch Clin Exp Ophthalmol 2016; 254: 315–22.
Vazirani J, Wurity S, Ali MH: Multidrug-resistant pseudomonas aeruginosa keratitis: risk factors, clinical characteristics, and outcomes. Ophthalmology 2015; 122: 2110–4
Castillo M, Scott NW, Mustafa MZ, et al. Topical antihistamines and mast cell stabilisers for treating sea - sonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev 2015; 6: CD009566.
Chi JJ: Management of the eye in facial paralysis. Facial Plast Surg Clin North Am 2016; 24: 21–8.
Wright C, Tawfik MA, Waisbourd M, et al Primary angle-closure glaucoma: an update. Acta Ophthalmol 2016; 94: 217–25.
Schwenn O: Acute angle closure, chronic angle-closure glaucoma and their differential diagnoses. Klin Monbl Augenheilkd 2011; 228: 95–104.
Silpa-Archa S, Oray M, Preble JM, et al. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmol 2016; 94: e400–6.
Suhler EB, Lim LL, Beardsley RM, et al.: Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology 2014; 121: 1885–91.
